Relationship of Platelet Reactivity to Cardiac Outcomes and Cardiac Risk Factors in Patients Receiving P2Y12 Platelet Inhibitors Following Percutaneous Coronary Intervention
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
This study will evaluate:
1- The relationship between PRU to peri-procedural cardiac outcomes, including bleeding.
2- The relationship of PRU to the cardiac risk factors.
3- The relationship of PRU to the extent of CAD (i.e. 1, 2 or 3 vessel disease).
Description
This study will evaluate:
1- The relationship between PRU to peri-procedural cardiac outcomes, including bleeding.
2- The relationship of PRU to the cardiac risk factors.
3- The relationship of PRU to the extent of CAD (i.e. 1, 2 or 3 vessel disease).
Details
| Age | 100years or below |
|---|---|
| Clinical Study Identifier | TX2283 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.